Sakai Arata, Shiomi Hideyuki, Iemoto Takao, Nakano Ryota, Ikegawa Takuya, Kobayashi Takashi, Masuda Atsuhiro, Kodama Yuzo
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Gastroenterology, Kitaharima Medical Center, Ono, Japan.
Clin Endosc. 2020 Jul;53(4):491-496. doi: 10.5946/ce.2019.145. Epub 2020 Mar 3.
In this study, we assessed a series of our cases in which endoscopic self-expandable metal stents (SEMSs) were used to treat malignant afferent loop obstruction (ALO) that arose after pancreaticoduodenectomy (PD). We retrospectively examined the records of 7 patients who underwent endoscopic SEMS placement for malignant ALO following PD. Clinical success was achieved in all cases. The median procedure time was 30 min (range, 15-50 min). There were no cases of stent occlusion, and no procedure-related adverse events were encountered. All patients died of their primary disease, and the median overall survival period was 155 days (range, 96-374 days). A re-intervention involving endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting was performed for obstructive jaundice and acute cholangitis in 1 case. In conclusion, endoscopic SEMS placement may be an effective and safe treatment for malignant ALO that arises after PD.
在本研究中,我们评估了一系列使用内镜下自膨式金属支架(SEMS)治疗胰十二指肠切除术(PD)后出现的恶性输入袢梗阻(ALO)的病例。我们回顾性检查了7例因PD后恶性ALO接受内镜下SEMS置入术患者的记录。所有病例均取得临床成功。中位手术时间为30分钟(范围15 - 50分钟)。无支架闭塞病例,未发生与手术相关的不良事件。所有患者均死于原发性疾病,中位总生存期为155天(范围96 - 374天)。1例患者因梗阻性黄疸和急性胆管炎接受了内镜超声引导下肝胃吻合术联合顺行支架置入的再次干预。总之,内镜下SEMS置入术可能是治疗PD后出现的恶性ALO的一种有效且安全的方法。